D

Dana-Farber Cancer Institute

World-Leading Cancer Research & Treatment

Boston, MA
5,000+

About Dana-Farber Cancer Institute

Industry: Cancer Research & Healthcare
Founded: 1947
Founders: Sidney Farber
Status: Non-Profit Academic Medical Center

Funding & Growth

Total Raised: N/A
Valuation: Non-profit
Stage: Established Institution
Key Investors:
NIH Grants Philanthropy Industry Partnerships

Pros

  • World-class cancer research environment
  • Access to unique clinical datasets and biospecimens
  • Collaboration with Harvard Medical School
  • Strong publication culture and academic freedom
  • Mission-driven work fighting cancer
  • Excellent networking in Boston biotech

Cons

  • Lower salaries than industry
  • Academic bureaucracy and slow hiring
  • Limited career ladder compared to industry
  • Grant funding dependency
  • Some positions are soft-money (grant-funded)

🏢 Working Here

Dana-Farber is one of the world's premier cancer research institutions, consistently ranked among the top cancer hospitals in the US.

Bioinformaticians here work alongside world-renowned oncologists and researchers, analyzing genomic data from thousands of cancer patients.

The Broad Institute is just across the street, enabling seamless collaboration on cutting-edge computational methods.

Teams are organized by disease area (breast, lung, pediatric cancers) or by platform (single-cell, spatial, clinical genomics).

Work involves developing novel analytical methods for tumor genomics, integrating multi-omic datasets, and translating research findings into clinical applications.

The Profile project, which sequences all consenting patients' tumors, provides access to one of the world's largest clinically-annotated cancer genomics datasets.

The environment is highly collaborative, with regular seminars, journal clubs, and cross-institutional projects with MIT, Harvard, and Mass General.

While salaries are lower than industry, the mission-driven culture and research impact attract top talent.

🧬 Bioinformatics Focus

Dana - Farber's bioinformatics work spans:

  • Tumor Genomics - Whole exome/genome sequencing of thousands of tumors, variant calling, mutation signatures, and clonal evolution analysis.
  • Single - Cell Analysis - scRNA-seq and scATAC-seq of tumor microenvironments, immune cell profiling, and spatial transcriptomics using Visium and Xenium platforms.
  • Translational Research - Developing companion diagnostics, biomarker discovery for immunotherapy response, and clinical trial genomics support.
  • Computational Oncology - Machine learning for drug response prediction, cancer subtype classification, and survival modeling.
  • Data Integration - Multi-omic integration (DNA, RNA, protein, metabolomics) for comprehensive tumor characterization. Key infrastructure includes the Center for Computational Oncology and collaborations with the Broad Institute's Cancer Program.

📈 Career Growth & Development

Career Paths

Research Track

Research Associate Computational Scientist Senior Scientist Associate Director Director

Faculty Track

Instructor Assistant Professor Associate Professor Full Professor
🎓

Academic Environment

Harvard Medical School affiliation provides access to world-class seminars, courses, and collaborations.

📝

Publication Culture

Strong emphasis on publishing in high-impact journals. First-author papers common for bioinformaticians.

🚀

Career Launchpad

Many alumni transition to faculty positions at top universities or leadership roles at biotech startups.

🤝

Network

The Longwood Medical Area provides unparalleled networking with HMS, Broad, Partners, and Boston Children's.

Perks & Benefits

Harvard Medical School access
Broad Institute collaboration
Generous vacation time
Tuition assistance
MBTA transit benefits
Flexible work arrangements
Retirement matching

Popular Teams

Center for Computational Oncology Genomics Platform Profile / OncoPanel Single-Cell Lab Data Sciences Clinical Bioinformatics